<DOC>
	<DOCNO>NCT00722501</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics ascend single IV dose ERB-257 healthy subject</brief_summary>
	<brief_title>Study Evaluating Safety Pharmacokinetics Ascending Single IV Doses ERB-257</brief_title>
	<detailed_description />
	<criteria>1 . Healthy men woman nonchildbearing potential age 18 50 . 2 . Body mass index ( BMI ) range 18.0 30.0 kg/m2 body weight great equal 50 kg2 . 3 . Have high probability compliance completion study . 1 . Presence history disorder may prevent successful completion study . 2 . Acute disease state ( eg , nausea , vomit , fever , diarrhea ) within 7 day study day 1 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>